Brief: Brooklyn Immunotherapeutics Announces Results Of Phase 2 Study Of IRX-2 In Head And Neck Cancer

Ernexa Therapeutics

26/07/2022 12:55

July 26 (Reuters) - Brooklyn Immunotherapeutics Inc  BTX.O :
    * BROOKLYN IMMUNOTHERAPEUTICS ANNOUNCES RESULTS OF PHASE 2
STUDY
OF IRX-2 IN HEAD AND NECK CANCER
    * BROOKLYN IMMUNOTHERAPEUTICS INC - PLANS TO PRESENT RESULTS
OF
INSPIRE STUDY AT A SCIENTIFIC CONFERENCE LATER THIS YEAR

Source text for Eikon:  ID:nGNX4HBZLQ 
Further company coverage:  BTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))